SCN8A and epilepsy: While a recent study reported that fenfluramine was able to significantly reduce seizure frequency in three patients with SCN8A-derived epilepsy (Aledo-Serrano et al., 2022), we did not observe any significant effect on susceptibility to 6 Hz-induced seizures in RL/+ mutants treated with fenfluramine (Figure 2E).